SlideShare a Scribd company logo
1 of 78
Download to read offline
Advocating for Change
Presenters:
• Gary Mendell, MBA, Founder and CEO, Shatterproof
• Kim Manlove, MS, AB, Director, Indiana Addictions
Issues Coalition
Advocacy Track
Moderator: Wendy Spencer, CEO, Corporation
for National and Community Service
Disclosures
Kim Manlove, MS, AB; Gary Mendell, MBA; and
Wendy Spencer have disclosed no relevant, real,
or apparent personal or professional financial
relationships with proprietary entities that
produce healthcare goods and services.
Disclosures
• All planners/managers hereby state that they or their
spouse/life partner do not have any financial
relationships or relationships to products or devices
with any commercial interest related to the content of
this activity of any amount during the past 12 months.
• The following planners/managers have the following to
disclose:
– John J. Dreyzehner, MD, MPH, FACOEM – Ownership
interest: Starfish Health (spouse)
– Robert DuPont – Employment: Bensinger, DuPont &
Associates-Prescription Drug Research Center
Learning Objectives
1. Advocate for state laws that mandate usage
of state PDMPs.
2. Explain strategies to influence passage of
legislation.
3. Describe how people in recovery from
addiction can become advocates through
recovery messaging training.
4. Provide accurate and appropriate counsel as
part of the treatment team.
Advocating for Change
Gary Mendell, Shatterproof
Our Story
Overdose Epidemic
This Epidemic Caused By Overprescribing of Opioids
The Bigger Solutions
Type Population Stage of
Intervention
Solutions
Those Not Addicted 320MM
Future Generations
Prevention PDMP
Prescriber Guidelines
Those with an OUD 3MM Treatment Prescriber Guidelines
MAT
PDMP
Those with an OUD 3MM Rescue Good Samaritan
Naloxone
Legislative Accomplishments
Legislative Accomplishments
•Wisconsin (Mandating use of their PDMP, February ‘16)
•Connecticut (Expanded access to Naloxone, Mandating use of PDMP
and Mandating prescriber education, June ’15)
•Florida (Expanded access to Naloxone, May ’15)
•Kentucky (Expanded access to Naloxone and No-Charge Good
Samaritan Protection, March ’15)
•West Virginia (Expanded Naloxone, February ’15)
•Pennsylvania (Expanded access to Naloxone, September ‘14)
•Delaware (Expanded access to Naloxone, August ‘14)
Today’s Focus: PDMP’s
• State-run databases that collect data regarding controlled
substance prescriptions
• Doctors review data prior to writing Rx to prevent lethal
combinations
• PDMP’s key state-level interventions:
– improve opioid prescribing
– inform clinical practice
– protect patients at risk
Key Legislative Components
• Query Prior to Prescribing Schedule II, II & IV Drugs
• Dispensers Submit Data within 24 hours of dispensing
• Authorized Recipients
• Delegates
• Proactive Analysis and Issuance of Unsolicited Reports
• De-Identified Information
• Interstate Sharing
• Evaluation
• Data as Early Warning System for Communities
2016 State Initiatives
2016 Advocacy Resources
• Quarterback Legislation Firm –
• State Based Lobbyist – Marc Burgat
• State Based PR Firm –
• Shatterproof Ambassadors, Influencers
• Fact Sheet, Case Study
CA Key Legislative Components
• Query Prior to Prescribing Schedule II, II & IV Drugs
• Dispensers Submit Data within 24 hours of dispensing
• Authorized Recipients
• Delegates
• Proactive Analysis and Issuance of Unsolicited Reports
• De-Identified Information
• Interstate Sharing
• Evaluation
• Data as Early Warning System for Communities
_
_
California had the largest number of
overdose deaths of any state in the
nation in 2014, 4,395. (CDC)California
had the largest number of
overdose deaths of any state in
the nation in 2014, 4,395. (CDC)
In states without a legislative mandate
to check the PDMP before prescribing
a controlled substance, ~86% of
prescriptions are written for an opioid
without ever checking the patient’s
prescription history.
(Brandeis University PDMP Center of
Excellence)
States with mandatory querying see lower
levels of opioid prescribing. In 2013, several
months after rolling out its new PDMP
software, New York passed legislation
consistent with the recommendations in the
box below. In the first year, doctor shopping
decreased 75%, the number of doses of
opioids dispensed decreased by 10% and the
number of buprenorphine prescriptions (a
drug used to treat opioid addiction) increased
by 15%. (See New York Case Study) Similar
results have been achieved in several other
states. (Brandeis University PDMP Center of
Excellence).
Progress in California
Senator Lara (D-Los Angeles) has taken leadership of this
issue and introduced legislation that would require
physician PDMP reporting.
The bill SB482:
• Mandates that the prescriber consults CURES
before prescribing a Schedule II or III controlled
substance for the first time and again annually if the
substance remains part of the treatment.
• Stipulates that failure to comply is subject to
disciplinary action by the appropriate licensing Board.
We recommend this bill should also include these
requirements:
• Expand mandatory query requirements to include
Schedule II through IV substances.
• Require prescribers to query the system upon
every prescription rather than annually.
• Require pharmacists to submit prescription
information to the PDMP within 24 hours of dispensing
(currently 7 days in CA).
• Publish findings on statewide opioid overdose
data to ascertain ways to further reduce overdoses.
How many states have
these provisions?
gmendell@shatterproof.org
How Can You Help?
Together, We Can Save Lives
25
Our Stories Of
Recovery From Addiction
Contain Incredible Power
26
William Cope Moyers of
Hazelden Treatment CenterWhy is it important
to share stories of
Recovery
27
Our Goals • Learning about messaging
• Learning how to tell your
recovery story to your friends
and family
• Learning how to use recovery
messages in all parts of your
life, including representing the
organized recovery
community in the media and
other public places
28
Recovery
Community
People in recovery from alcohol and
other drug addiction, their family members,
friends and allies
29
Faces &
Voices of
Recovery
• Organizing and mobilizing the millions of
Americans in long-term recovery from
alcohol and other drug addiction, our
families, friends, and allies, to speak with
one voice.
• Changing public perceptions of recovery
• Promoting effective public policy in
Washington, D.C. and in all 50 states
• Keeping a focus on the fact that recovery
works and is making life better for over 20
million Americans.
30
Faces &
Voices of
Recovery
• Raises the recovery movement’s
national profile
• Supports local recovery advocacy
and recovery community
organizations
It is our mission to bring the
power and proof of recovery
to everyone in America!
Many
Pathways to
Recovery
• Mutual support/mutual assistance
• Professional treatment
• Faith/religious
• Medication-assisted
• Criminal justice/Drug Court
• “Natural” or on your own
• And many more
32
Message of
Hope
“Many of us have carried a message of
hope on a one-to-one basis; this new
recovery movement calls upon us to
carry that message of hope to whole
communities and the whole culture. It is
time we stepped forward to shape this
history with our stories, our time and our
talents.”
-William White Author and Recovery Advocate
33
What is a
Message?
• An exchange of information using
words
• The most important information
you want your listener to hear
It is crucial that you know what
you want to say and leave in
people’s minds.
34
Grounded in
Research
Recovery Community
• 88% believe it is very important for
the American public to see that
thousands get well every year
General Public
• A majority of Americans (63%)
have been affected by addiction
• A majority (67%) believe that there
is a stigma toward people in
recovery
• A majority (74%) say that attitudes
& policies must change
35
Who are You
Talking to?
• Family
• Friends
• Neighbors
• Co-workers
• Media
• Public officials
36
Your
Frame
of Mind
• Speak with one voice
• Make it personal; it
adds credibility and
breaks down
misperceptions
• Talk about your
recovery, not your
addiction – your
recovery story
37
12-Step
Anonymity • These messages
don’t violate the
traditions of your
12-step fellowship
• Help us educate
others in 12-step
groups about their
right to speak out!
38
Core
Message The Problem:
• Need more opportunities for
people to achieve long-term
recovery
• Need more effective treatment
and recovery support services
• There are discriminatory policies
• The public and policymakers
don’t know about the reality of
recovery
39
Core
Message The Solution:
• A strong national recovery
movement organized at the
local, state and federal
levels
• Putting a face and a voice
on recovery to break down
misperceptions that will
change attitudes (stigma)
• Advocating to change
policies (discrimination)
40
Putting a Face
& a Voice on
Recovery:
Message
for a Person
in Recovery
I’m in long-term recovery which
means...
• Have not used alcohol or other
drugs for x number years
• Long-term recovery has given me
new hope and stability
• I’ve been able to create a better
life for myself, my family and my
community
• I’m speaking out so that others
have the opportunity to achieve
long-term recovery
41
Putting a
Face & a
Voice on
Recovery:
Message
for a
Family
Member
I and my family are in long-term
recovery, which means …
• (My son/daughter/husband/wife)
hasn’t used alcohol or other drugs
for x years
• We’ve become healthier together,
enjoying family life in our home
• Long-term recovery has given me
and my family new purpose and
hope for the future
• I want to make it possible for others
to do the same
42
What’s Not
in the
Message
and Why
• I’m an addict (or alcoholic)
• I’m a recovering addict (or
alcoholic)
• Addiction is a disease
• Information about 12-step
programs, for examples
membership in AA or NA or Al-
Anon
• A “definition” of recovery
43
Words
Have
Power
“Words have immense power to wound or
heal…The right words catalyze personal
transformation and offer invitations to
citizenship and community service. The
wrong words stigmatize and dis-empower.”
-William White Author
and Recovery Advocate
44
Thinking
about
Language
Words/Concepts We Need to Abandon
Abuse
Self-Help
Untreated Alcoholics/Untreated Addicts
The Language of Self-Pity
Words/Concepts to Discuss and Debate
Treatment Works
Consumer
Stigma, Enable, Relapse
Recovering/Recovered
45
Thinking
about
Language
Words/Concepts We Need to Elevate
and Celebrate
•Recovery, Recovery Community/
Communities of Recovery
•Advocacy, Sustainability
•Recovery Support Services/
Recovery Coach
•Recovery-Oriented Systems of Care
•Living Proof
•Story
•Responsibility, Gratitude, Service
46
Faces &
Voices
Message
Goals
• Expand opportunities for recovery
• Mobilize and organize the recovery
community to advocate for own rights
and needs
• Break down discriminatory barriers
• Build our national recovery advocacy
movement
• Achieve a just response to addiction
as a health crisis
47
When can I
Use the
Message?
• When talking to your family,
friends and neighbors
• When writing (articles,
newsletters, blogging, etc.)
• When talking to elected officials,
public policy makers and others in
government
• When being interviewed or
speaking in public
• ALWAYS!
48
Audience
• The reporter is NOT your audience – it
is the viewer, listener or reader
• Think about talking to someone you
know
Never lose sight of who you are trying to
reach
49
Techniques:
Working with
a Reporter
and Staying
on Message
If you get a question you don’t want to
answer, change the question by using a
transitional or “pivoting” phrase such as:
• “Another thing to remember…”
• “That’s not my area of expertise, but what
I can tell you is…”
• “Another way of thinking about this is…”
• “Thank you for asking…”
• “The most important thing to remember…”
50
Techniques:
Staying on
Message
Q. “Some people believe addiction is a
personal or moral weakness. How
do you respond?”
A. “More important than addiction…is
recovery. The fact is that treatment
and recovery have proven to work
for millions of Americans like me.”
51
Techniques:
Staying on
Message
Q. “What was it like to be an addict?”
“What I can tell you about is recovery.
As a person in long-term recovery,
I’ve been able to create a better life
for myself and my family. Over the
last 15 years, I’ve bought a house,
have a great job and am a parent to
three wonderful kids.”
52
Recovery
Messaging
Resources
• Recovery Messaging from Faces &
Voices of Recovery
• Recovery Messaging Questions &
Answers
• The Tip Sheet for Media Interviews
• Our Stories Have Power DVD
featuring interviews by people in
recovery, family members and friends
53
Summary • Use Faces & Voices recovery
messaging to tell your recovery
story
• Make it personal
• Use your message in all parts of
your life with
Family and friends
Neighbors and co-workers
Media and public officials
Always!
54
Our Goals
• Learn tips to prepare for interviews
• Learn techniques for working with
reporters
• Learn tips on how to look, act and
speak your best
55
Preparation
• Decide if this interview makes
sense for you and your
organization
• Determine your primary goal in
participating in the interview
• Role play the interview and
rehearse hard questions
• Visualize your audience and
speak to them as though they
were in the room
• Assume that everything you
say will be recorded or written
down
56
Prepare for
Interviews:
Know Your
Message
• Know in advance which points
you want to get across – work
them into your responses
• Focus on your key points, not
the interviewer’s points
57
Prepare for
Interviews:
Deliver Your
Message
• Use colorful language such as
metaphors or analogies that help to
make your point to increase the
likelihood of being quoted
Example: “Recovery helped
me pick up the shattered
pieces of my life.”
• Use anecdotes from your work, your
life and your community to support
your points
• Speak in lay person’s terms – if you
must use jargon or technical
language, explain it
58
Why is it
important to
share stories
of Recovery
Actress and Comedienne
Kristen Johnston
59
Prepare for
Interviews:
Facts You
Can Use
• Tens of thousands of Americans
recover from addiction every year
• Over 20 million Americans are in
long-term recovery from addiction
• Untreated addiction costs the US
over $450 billion every year
60
Prepare for
Interviews:
Facts You
Can Use
• 75% of people with alcohol or other
drug problems are employed.
• Jails and prisons are over crowded
with a majority of inmates having
committed alcohol or drug-related
crimes.
• More than eight out of every ten
Americans who need services for
addiction to alcohol and other drugs
are not receiving the help they need
to get well.
61
Techniques:
Working with
a Reporter
and Staying
on Message
If you get a question you don’t want
to answer, change the question by
using a transitional or “pivoting”
phrase such as:
• “Another thing to remember…”
• “That’s not my area of expertise,
but what I can tell you is…”
• “Another way of thinking about
this is…”
• “Thank you for asking…”
• “The most important thing to
remember…”
62
Techniques:
Staying on
Message
Q. “Some people believe addiction
is a personal or moral
weakness. How do you
respond?”
“More important than
addiction…is recovery. The fact
is that just like me, over 20
million Americans are in long-
term recovery from addiction.
63
Techniques:
Staying on
Message
Q. “What was it like to be an
addict?”
“What I can tell you about is
recovery. As a person in long-
term recovery, I’ve been able to
create a better life for myself
and my family. Over the last 15
years, I’ve bought a house,
have a great job and am a
parent to three wonderful kids.”
64
Techniques:
Speaking
Effectively
• Be brief – responses to
questions should be short; 18-
30 second sound bites.
• THE HARD TRUTH: IF IT
ISN’T SHORT IT DOESN’T
GET USED
“For the first time, the recovery
community is speaking in one
voice to change the public
perception of recovery and to
promote effective public
policy.”
65
Keys to
Successful
Television
Interviews
• Be prepared to make only one point
• Talk as though you were talking with
a friend
• Expressions
• Overemphasize positive
expressions (negative
characteristics are exaggerated
on TV)
• SMILE
66
Pre-Interview
• Make sure you have water
• Introduce yourself to the
technicians
• Chat with the interviewer before it
starts
• Make clear what you want to
cover
• Get a sense of what she wants
to discuss
67
Posture and
Eye Contact
• Sit as far back in your chair as
possible
• Lean slightly forward
• Maintain eye contact with the
interviewer
68
Appearance
Men
• Darker suits are best
• Red, maroon or gray ties
without distracting patterns
are best
• Socks should be same or
darker color than suit
69
Appearance
Women
• Dress in neutrals and avoid large
patterns
• Don’t wear big jewelry
• Don’t wear too much or too bright
lipstick
70
Keys to
Successful
Radio
Interviews
• Keep your answers short
Generally only one or two sound
bites will be used
• If it’s a phone interview, stand up
• Be expressive and animated
• Speak clearly and at a moderate
pace
71
Keys to
Successful
Print
Interviews
• While often longer, use only a small
portion of what you say gets used
• In the longer format, it’s easier to
get off track
• Remember your key message and
deliver it
• Flag your key messages by saying
things like “the most important point”
or “what people should really know
is”
72
Keys to
Successful
Print
Interviews
• Don’t let your guard down.
Remember anything you say
can be included in the story
• Hard questions don’t mean that
the reporter has taken a side
• If you are unsure of an answer,
tell the reporter that you will get
back to them
73
Summary
• Prepare for your interview
Know your key messages
Practice
Dress appropriately
• Deliver your key messages
• Think about your audience
Use your voice
Maintain eye contact
• Stay on message
74
Conclusion
• Use Faces & Voices recovery
messaging to tell your recovery story
• Make it personal
• Use your message in all parts of your
life with
Family and friends
Neighbors and co-workers
Media and public officials
Always!
75
Why Is It Important
To Share Our Stories
If I Only Knew How
Important It Is To Put
A Face On Recovery!!
76
Unite to Face Addiction 2015
Rally for Recovery Washington DCAnd once you
have shared
your story-
you will join
thousands of
us who have
United to
Face
Addiction
77
Kim Manlove, Director
Indiana Addictions Issues Coalition
Mental Health America of Indiana
kim.m@the24group.org
317-331-5949
Advocating for Change
Presenters:
• Gary Mendell, MBA, Founder and CEO, Shatterproof
• Kim Manlove, MS, AB, Director, Indiana Addictions
Issues Coalition
Advocacy Track
Moderator: Wendy Spencer, CEO, Corporation
for National and Community Service

More Related Content

What's hot

Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
 
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conoverRx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conoverOPUNITE
 
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriendRx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriendOPUNITE
 
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbinsRx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbinsOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrownRx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrownOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonOPUNITE
 
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4travenRx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4travenOPUNITE
 
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsazRx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsazOPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasOPUNITE
 
Rx16 workshop 200_group_ppt
Rx16 workshop 200_group_pptRx16 workshop 200_group_ppt
Rx16 workshop 200_group_pptOPUNITE
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerOPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliOPUNITE
 
Rx16 federal tues_200_1_gladden_2halpin_3green
Rx16 federal tues_200_1_gladden_2halpin_3greenRx16 federal tues_200_1_gladden_2halpin_3green
Rx16 federal tues_200_1_gladden_2halpin_3greenOPUNITE
 

What's hot (20)

Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conoverRx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
 
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriendRx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriend
 
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbinsRx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrownRx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
 
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4travenRx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
 
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsazRx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haas
 
Rx16 workshop 200_group_ppt
Rx16 workshop 200_group_pptRx16 workshop 200_group_ppt
Rx16 workshop 200_group_ppt
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashley
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2waller
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Rx16 federal tues_200_1_gladden_2halpin_3green
Rx16 federal tues_200_1_gladden_2halpin_3greenRx16 federal tues_200_1_gladden_2halpin_3green
Rx16 federal tues_200_1_gladden_2halpin_3green
 

Viewers also liked

Rx16 vs appriss_tues_800_group
Rx16 vs appriss_tues_800_groupRx16 vs appriss_tues_800_group
Rx16 vs appriss_tues_800_groupOPUNITE
 
Rx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okesonRx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okesonOPUNITE
 
Rx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonRx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonOPUNITE
 
Rx16 clinical tues_1115_group
Rx16 clinical tues_1115_groupRx16 clinical tues_1115_group
Rx16 clinical tues_1115_groupOPUNITE
 
Rx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupRx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupOPUNITE
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderRx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderOPUNITE
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Rx16 heroin tues_1115_1_walls_2kolodny
Rx16 heroin tues_1115_1_walls_2kolodnyRx16 heroin tues_1115_1_walls_2kolodny
Rx16 heroin tues_1115_1_walls_2kolodnyOPUNITE
 
Rx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenRx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenOPUNITE
 
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroWeb only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroOPUNITE
 

Viewers also liked (13)

Rx16 vs appriss_tues_800_group
Rx16 vs appriss_tues_800_groupRx16 vs appriss_tues_800_group
Rx16 vs appriss_tues_800_group
 
Rx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okesonRx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okeson
 
Rx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonRx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_walton
 
Rx16 clinical tues_1115_group
Rx16 clinical tues_1115_groupRx16 clinical tues_1115_group
Rx16 clinical tues_1115_group
 
Rx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupRx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_group
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderRx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 heroin tues_1115_1_walls_2kolodny
Rx16 heroin tues_1115_1_walls_2kolodnyRx16 heroin tues_1115_1_walls_2kolodny
Rx16 heroin tues_1115_1_walls_2kolodny
 
Rx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenRx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3green
 
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroWeb only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
 

Similar to Rx16 advocacy wed_200_1_mendell_2manlove

Rx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williamsRx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williamsOPUNITE
 
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwards
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwardsRx15 ea tues_330_1_lovedale_2holton_3varney-edwards
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwardsOPUNITE
 
Aca advocacy
Aca advocacyAca advocacy
Aca advocacyschacctf
 
Rx15 pdmp wed_430_1_stanton_2blake_3ramsey
Rx15 pdmp wed_430_1_stanton_2blake_3ramseyRx15 pdmp wed_430_1_stanton_2blake_3ramsey
Rx15 pdmp wed_430_1_stanton_2blake_3ramseyOPUNITE
 
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxton
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxtonRx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxton
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxtonOPUNITE
 
SAM - marijuana and the workplace
SAM - marijuana and the workplaceSAM - marijuana and the workplace
SAM - marijuana and the workplaceSAM
 
Welfare and Drug Testing Policy in the USA
Welfare and Drug Testing Policy in the USAWelfare and Drug Testing Policy in the USA
Welfare and Drug Testing Policy in the USAFaisal Farrukh
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Tuesday partnership
Tuesday partnershipTuesday partnership
Tuesday partnershipOPUNITE
 
Rx15 ea wed_300_1_perry-martin_2wethington
Rx15 ea wed_300_1_perry-martin_2wethingtonRx15 ea wed_300_1_perry-martin_2wethington
Rx15 ea wed_300_1_perry-martin_2wethingtonOPUNITE
 
System Innovation in California: The Impact of MHSA
System Innovation in California: The Impact of MHSASystem Innovation in California: The Impact of MHSA
System Innovation in California: The Impact of MHSAcommteam
 
Susan Shepherd - Panel - Alternatives to the War on Drugs
Susan Shepherd - Panel - Alternatives to the War on DrugsSusan Shepherd - Panel - Alternatives to the War on Drugs
Susan Shepherd - Panel - Alternatives to the War on DrugsCSSDPUofT
 
Rx15 le wed_1115_1_meinhofer_2simon-worthy
Rx15 le wed_1115_1_meinhofer_2simon-worthyRx15 le wed_1115_1_meinhofer_2simon-worthy
Rx15 le wed_1115_1_meinhofer_2simon-worthyOPUNITE
 
Grassroots basics
Grassroots basicsGrassroots basics
Grassroots basicsShcl1438
 
Health Equity for Immigrants and Refugees: Driving Policy Action
Health Equity for Immigrants and Refugees: Driving Policy ActionHealth Equity for Immigrants and Refugees: Driving Policy Action
Health Equity for Immigrants and Refugees: Driving Policy ActionWellesley Institute
 
Rx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptageRx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptageOPUNITE
 
Office-Based Opioid Treatment: What You Need to Know: Trends in Behavioral He...
Office-Based Opioid Treatment: What You Need to Know: Trends in Behavioral He...Office-Based Opioid Treatment: What You Need to Know: Trends in Behavioral He...
Office-Based Opioid Treatment: What You Need to Know: Trends in Behavioral He...Epstein Becker Green
 
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal ElectionSummer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal ElectionCanadian Organization for Rare Disorders
 

Similar to Rx16 advocacy wed_200_1_mendell_2manlove (20)

Rx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williamsRx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williams
 
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwards
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwardsRx15 ea tues_330_1_lovedale_2holton_3varney-edwards
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwards
 
Aca advocacy
Aca advocacyAca advocacy
Aca advocacy
 
Rx15 pdmp wed_430_1_stanton_2blake_3ramsey
Rx15 pdmp wed_430_1_stanton_2blake_3ramseyRx15 pdmp wed_430_1_stanton_2blake_3ramsey
Rx15 pdmp wed_430_1_stanton_2blake_3ramsey
 
Contemporary Advocacy Marketing in Healthcare
Contemporary Advocacy Marketing in HealthcareContemporary Advocacy Marketing in Healthcare
Contemporary Advocacy Marketing in Healthcare
 
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxton
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxtonRx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxton
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxton
 
SAM - marijuana and the workplace
SAM - marijuana and the workplaceSAM - marijuana and the workplace
SAM - marijuana and the workplace
 
Welfare and Drug Testing Policy in the USA
Welfare and Drug Testing Policy in the USAWelfare and Drug Testing Policy in the USA
Welfare and Drug Testing Policy in the USA
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Tuesday partnership
Tuesday partnershipTuesday partnership
Tuesday partnership
 
Rx15 ea wed_300_1_perry-martin_2wethington
Rx15 ea wed_300_1_perry-martin_2wethingtonRx15 ea wed_300_1_perry-martin_2wethington
Rx15 ea wed_300_1_perry-martin_2wethington
 
System Innovation in California: The Impact of MHSA
System Innovation in California: The Impact of MHSASystem Innovation in California: The Impact of MHSA
System Innovation in California: The Impact of MHSA
 
Susan Shepherd - Panel - Alternatives to the War on Drugs
Susan Shepherd - Panel - Alternatives to the War on DrugsSusan Shepherd - Panel - Alternatives to the War on Drugs
Susan Shepherd - Panel - Alternatives to the War on Drugs
 
Rx15 le wed_1115_1_meinhofer_2simon-worthy
Rx15 le wed_1115_1_meinhofer_2simon-worthyRx15 le wed_1115_1_meinhofer_2simon-worthy
Rx15 le wed_1115_1_meinhofer_2simon-worthy
 
Healthcare in Canada - Who Does What?
Healthcare in Canada - Who Does What?Healthcare in Canada - Who Does What?
Healthcare in Canada - Who Does What?
 
Grassroots basics
Grassroots basicsGrassroots basics
Grassroots basics
 
Health Equity for Immigrants and Refugees: Driving Policy Action
Health Equity for Immigrants and Refugees: Driving Policy ActionHealth Equity for Immigrants and Refugees: Driving Policy Action
Health Equity for Immigrants and Refugees: Driving Policy Action
 
Rx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptageRx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptage
 
Office-Based Opioid Treatment: What You Need to Know: Trends in Behavioral He...
Office-Based Opioid Treatment: What You Need to Know: Trends in Behavioral He...Office-Based Opioid Treatment: What You Need to Know: Trends in Behavioral He...
Office-Based Opioid Treatment: What You Need to Know: Trends in Behavioral He...
 
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal ElectionSummer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
 

More from OPUNITE

Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioOPUNITE
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyOPUNITE
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorOPUNITE
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200OPUNITE
 
Rx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenRx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenOPUNITE
 
Rx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinRx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinOPUNITE
 

More from OPUNITE (14)

Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200
 
Rx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenRx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2green
 
Rx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinRx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorin
 

Recently uploaded

Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 

Recently uploaded (20)

Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 

Rx16 advocacy wed_200_1_mendell_2manlove

  • 1. Advocating for Change Presenters: • Gary Mendell, MBA, Founder and CEO, Shatterproof • Kim Manlove, MS, AB, Director, Indiana Addictions Issues Coalition Advocacy Track Moderator: Wendy Spencer, CEO, Corporation for National and Community Service
  • 2. Disclosures Kim Manlove, MS, AB; Gary Mendell, MBA; and Wendy Spencer have disclosed no relevant, real, or apparent personal or professional financial relationships with proprietary entities that produce healthcare goods and services.
  • 3. Disclosures • All planners/managers hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. • The following planners/managers have the following to disclose: – John J. Dreyzehner, MD, MPH, FACOEM – Ownership interest: Starfish Health (spouse) – Robert DuPont – Employment: Bensinger, DuPont & Associates-Prescription Drug Research Center
  • 4. Learning Objectives 1. Advocate for state laws that mandate usage of state PDMPs. 2. Explain strategies to influence passage of legislation. 3. Describe how people in recovery from addiction can become advocates through recovery messaging training. 4. Provide accurate and appropriate counsel as part of the treatment team.
  • 5. Advocating for Change Gary Mendell, Shatterproof
  • 7. Overdose Epidemic This Epidemic Caused By Overprescribing of Opioids
  • 8. The Bigger Solutions Type Population Stage of Intervention Solutions Those Not Addicted 320MM Future Generations Prevention PDMP Prescriber Guidelines Those with an OUD 3MM Treatment Prescriber Guidelines MAT PDMP Those with an OUD 3MM Rescue Good Samaritan Naloxone
  • 10. Legislative Accomplishments •Wisconsin (Mandating use of their PDMP, February ‘16) •Connecticut (Expanded access to Naloxone, Mandating use of PDMP and Mandating prescriber education, June ’15) •Florida (Expanded access to Naloxone, May ’15) •Kentucky (Expanded access to Naloxone and No-Charge Good Samaritan Protection, March ’15) •West Virginia (Expanded Naloxone, February ’15) •Pennsylvania (Expanded access to Naloxone, September ‘14) •Delaware (Expanded access to Naloxone, August ‘14)
  • 11. Today’s Focus: PDMP’s • State-run databases that collect data regarding controlled substance prescriptions • Doctors review data prior to writing Rx to prevent lethal combinations • PDMP’s key state-level interventions: – improve opioid prescribing – inform clinical practice – protect patients at risk
  • 12. Key Legislative Components • Query Prior to Prescribing Schedule II, II & IV Drugs • Dispensers Submit Data within 24 hours of dispensing • Authorized Recipients • Delegates • Proactive Analysis and Issuance of Unsolicited Reports • De-Identified Information • Interstate Sharing • Evaluation • Data as Early Warning System for Communities
  • 14. 2016 Advocacy Resources • Quarterback Legislation Firm – • State Based Lobbyist – Marc Burgat • State Based PR Firm – • Shatterproof Ambassadors, Influencers • Fact Sheet, Case Study
  • 15. CA Key Legislative Components • Query Prior to Prescribing Schedule II, II & IV Drugs • Dispensers Submit Data within 24 hours of dispensing • Authorized Recipients • Delegates • Proactive Analysis and Issuance of Unsolicited Reports • De-Identified Information • Interstate Sharing • Evaluation • Data as Early Warning System for Communities
  • 16. _
  • 17. _ California had the largest number of overdose deaths of any state in the nation in 2014, 4,395. (CDC)California had the largest number of overdose deaths of any state in the nation in 2014, 4,395. (CDC)
  • 18. In states without a legislative mandate to check the PDMP before prescribing a controlled substance, ~86% of prescriptions are written for an opioid without ever checking the patient’s prescription history. (Brandeis University PDMP Center of Excellence)
  • 19. States with mandatory querying see lower levels of opioid prescribing. In 2013, several months after rolling out its new PDMP software, New York passed legislation consistent with the recommendations in the box below. In the first year, doctor shopping decreased 75%, the number of doses of opioids dispensed decreased by 10% and the number of buprenorphine prescriptions (a drug used to treat opioid addiction) increased by 15%. (See New York Case Study) Similar results have been achieved in several other states. (Brandeis University PDMP Center of Excellence).
  • 20. Progress in California Senator Lara (D-Los Angeles) has taken leadership of this issue and introduced legislation that would require physician PDMP reporting. The bill SB482: • Mandates that the prescriber consults CURES before prescribing a Schedule II or III controlled substance for the first time and again annually if the substance remains part of the treatment. • Stipulates that failure to comply is subject to disciplinary action by the appropriate licensing Board. We recommend this bill should also include these requirements: • Expand mandatory query requirements to include Schedule II through IV substances. • Require prescribers to query the system upon every prescription rather than annually. • Require pharmacists to submit prescription information to the PDMP within 24 hours of dispensing (currently 7 days in CA). • Publish findings on statewide opioid overdose data to ascertain ways to further reduce overdoses.
  • 21. How many states have these provisions?
  • 22.
  • 23.
  • 24. gmendell@shatterproof.org How Can You Help? Together, We Can Save Lives
  • 25. 25 Our Stories Of Recovery From Addiction Contain Incredible Power
  • 26. 26 William Cope Moyers of Hazelden Treatment CenterWhy is it important to share stories of Recovery
  • 27. 27 Our Goals • Learning about messaging • Learning how to tell your recovery story to your friends and family • Learning how to use recovery messages in all parts of your life, including representing the organized recovery community in the media and other public places
  • 28. 28 Recovery Community People in recovery from alcohol and other drug addiction, their family members, friends and allies
  • 29. 29 Faces & Voices of Recovery • Organizing and mobilizing the millions of Americans in long-term recovery from alcohol and other drug addiction, our families, friends, and allies, to speak with one voice. • Changing public perceptions of recovery • Promoting effective public policy in Washington, D.C. and in all 50 states • Keeping a focus on the fact that recovery works and is making life better for over 20 million Americans.
  • 30. 30 Faces & Voices of Recovery • Raises the recovery movement’s national profile • Supports local recovery advocacy and recovery community organizations It is our mission to bring the power and proof of recovery to everyone in America!
  • 31. Many Pathways to Recovery • Mutual support/mutual assistance • Professional treatment • Faith/religious • Medication-assisted • Criminal justice/Drug Court • “Natural” or on your own • And many more
  • 32. 32 Message of Hope “Many of us have carried a message of hope on a one-to-one basis; this new recovery movement calls upon us to carry that message of hope to whole communities and the whole culture. It is time we stepped forward to shape this history with our stories, our time and our talents.” -William White Author and Recovery Advocate
  • 33. 33 What is a Message? • An exchange of information using words • The most important information you want your listener to hear It is crucial that you know what you want to say and leave in people’s minds.
  • 34. 34 Grounded in Research Recovery Community • 88% believe it is very important for the American public to see that thousands get well every year General Public • A majority of Americans (63%) have been affected by addiction • A majority (67%) believe that there is a stigma toward people in recovery • A majority (74%) say that attitudes & policies must change
  • 35. 35 Who are You Talking to? • Family • Friends • Neighbors • Co-workers • Media • Public officials
  • 36. 36 Your Frame of Mind • Speak with one voice • Make it personal; it adds credibility and breaks down misperceptions • Talk about your recovery, not your addiction – your recovery story
  • 37. 37 12-Step Anonymity • These messages don’t violate the traditions of your 12-step fellowship • Help us educate others in 12-step groups about their right to speak out!
  • 38. 38 Core Message The Problem: • Need more opportunities for people to achieve long-term recovery • Need more effective treatment and recovery support services • There are discriminatory policies • The public and policymakers don’t know about the reality of recovery
  • 39. 39 Core Message The Solution: • A strong national recovery movement organized at the local, state and federal levels • Putting a face and a voice on recovery to break down misperceptions that will change attitudes (stigma) • Advocating to change policies (discrimination)
  • 40. 40 Putting a Face & a Voice on Recovery: Message for a Person in Recovery I’m in long-term recovery which means... • Have not used alcohol or other drugs for x number years • Long-term recovery has given me new hope and stability • I’ve been able to create a better life for myself, my family and my community • I’m speaking out so that others have the opportunity to achieve long-term recovery
  • 41. 41 Putting a Face & a Voice on Recovery: Message for a Family Member I and my family are in long-term recovery, which means … • (My son/daughter/husband/wife) hasn’t used alcohol or other drugs for x years • We’ve become healthier together, enjoying family life in our home • Long-term recovery has given me and my family new purpose and hope for the future • I want to make it possible for others to do the same
  • 42. 42 What’s Not in the Message and Why • I’m an addict (or alcoholic) • I’m a recovering addict (or alcoholic) • Addiction is a disease • Information about 12-step programs, for examples membership in AA or NA or Al- Anon • A “definition” of recovery
  • 43. 43 Words Have Power “Words have immense power to wound or heal…The right words catalyze personal transformation and offer invitations to citizenship and community service. The wrong words stigmatize and dis-empower.” -William White Author and Recovery Advocate
  • 44. 44 Thinking about Language Words/Concepts We Need to Abandon Abuse Self-Help Untreated Alcoholics/Untreated Addicts The Language of Self-Pity Words/Concepts to Discuss and Debate Treatment Works Consumer Stigma, Enable, Relapse Recovering/Recovered
  • 45. 45 Thinking about Language Words/Concepts We Need to Elevate and Celebrate •Recovery, Recovery Community/ Communities of Recovery •Advocacy, Sustainability •Recovery Support Services/ Recovery Coach •Recovery-Oriented Systems of Care •Living Proof •Story •Responsibility, Gratitude, Service
  • 46. 46 Faces & Voices Message Goals • Expand opportunities for recovery • Mobilize and organize the recovery community to advocate for own rights and needs • Break down discriminatory barriers • Build our national recovery advocacy movement • Achieve a just response to addiction as a health crisis
  • 47. 47 When can I Use the Message? • When talking to your family, friends and neighbors • When writing (articles, newsletters, blogging, etc.) • When talking to elected officials, public policy makers and others in government • When being interviewed or speaking in public • ALWAYS!
  • 48. 48 Audience • The reporter is NOT your audience – it is the viewer, listener or reader • Think about talking to someone you know Never lose sight of who you are trying to reach
  • 49. 49 Techniques: Working with a Reporter and Staying on Message If you get a question you don’t want to answer, change the question by using a transitional or “pivoting” phrase such as: • “Another thing to remember…” • “That’s not my area of expertise, but what I can tell you is…” • “Another way of thinking about this is…” • “Thank you for asking…” • “The most important thing to remember…”
  • 50. 50 Techniques: Staying on Message Q. “Some people believe addiction is a personal or moral weakness. How do you respond?” A. “More important than addiction…is recovery. The fact is that treatment and recovery have proven to work for millions of Americans like me.”
  • 51. 51 Techniques: Staying on Message Q. “What was it like to be an addict?” “What I can tell you about is recovery. As a person in long-term recovery, I’ve been able to create a better life for myself and my family. Over the last 15 years, I’ve bought a house, have a great job and am a parent to three wonderful kids.”
  • 52. 52 Recovery Messaging Resources • Recovery Messaging from Faces & Voices of Recovery • Recovery Messaging Questions & Answers • The Tip Sheet for Media Interviews • Our Stories Have Power DVD featuring interviews by people in recovery, family members and friends
  • 53. 53 Summary • Use Faces & Voices recovery messaging to tell your recovery story • Make it personal • Use your message in all parts of your life with Family and friends Neighbors and co-workers Media and public officials Always!
  • 54. 54 Our Goals • Learn tips to prepare for interviews • Learn techniques for working with reporters • Learn tips on how to look, act and speak your best
  • 55. 55 Preparation • Decide if this interview makes sense for you and your organization • Determine your primary goal in participating in the interview • Role play the interview and rehearse hard questions • Visualize your audience and speak to them as though they were in the room • Assume that everything you say will be recorded or written down
  • 56. 56 Prepare for Interviews: Know Your Message • Know in advance which points you want to get across – work them into your responses • Focus on your key points, not the interviewer’s points
  • 57. 57 Prepare for Interviews: Deliver Your Message • Use colorful language such as metaphors or analogies that help to make your point to increase the likelihood of being quoted Example: “Recovery helped me pick up the shattered pieces of my life.” • Use anecdotes from your work, your life and your community to support your points • Speak in lay person’s terms – if you must use jargon or technical language, explain it
  • 58. 58 Why is it important to share stories of Recovery Actress and Comedienne Kristen Johnston
  • 59. 59 Prepare for Interviews: Facts You Can Use • Tens of thousands of Americans recover from addiction every year • Over 20 million Americans are in long-term recovery from addiction • Untreated addiction costs the US over $450 billion every year
  • 60. 60 Prepare for Interviews: Facts You Can Use • 75% of people with alcohol or other drug problems are employed. • Jails and prisons are over crowded with a majority of inmates having committed alcohol or drug-related crimes. • More than eight out of every ten Americans who need services for addiction to alcohol and other drugs are not receiving the help they need to get well.
  • 61. 61 Techniques: Working with a Reporter and Staying on Message If you get a question you don’t want to answer, change the question by using a transitional or “pivoting” phrase such as: • “Another thing to remember…” • “That’s not my area of expertise, but what I can tell you is…” • “Another way of thinking about this is…” • “Thank you for asking…” • “The most important thing to remember…”
  • 62. 62 Techniques: Staying on Message Q. “Some people believe addiction is a personal or moral weakness. How do you respond?” “More important than addiction…is recovery. The fact is that just like me, over 20 million Americans are in long- term recovery from addiction.
  • 63. 63 Techniques: Staying on Message Q. “What was it like to be an addict?” “What I can tell you about is recovery. As a person in long- term recovery, I’ve been able to create a better life for myself and my family. Over the last 15 years, I’ve bought a house, have a great job and am a parent to three wonderful kids.”
  • 64. 64 Techniques: Speaking Effectively • Be brief – responses to questions should be short; 18- 30 second sound bites. • THE HARD TRUTH: IF IT ISN’T SHORT IT DOESN’T GET USED “For the first time, the recovery community is speaking in one voice to change the public perception of recovery and to promote effective public policy.”
  • 65. 65 Keys to Successful Television Interviews • Be prepared to make only one point • Talk as though you were talking with a friend • Expressions • Overemphasize positive expressions (negative characteristics are exaggerated on TV) • SMILE
  • 66. 66 Pre-Interview • Make sure you have water • Introduce yourself to the technicians • Chat with the interviewer before it starts • Make clear what you want to cover • Get a sense of what she wants to discuss
  • 67. 67 Posture and Eye Contact • Sit as far back in your chair as possible • Lean slightly forward • Maintain eye contact with the interviewer
  • 68. 68 Appearance Men • Darker suits are best • Red, maroon or gray ties without distracting patterns are best • Socks should be same or darker color than suit
  • 69. 69 Appearance Women • Dress in neutrals and avoid large patterns • Don’t wear big jewelry • Don’t wear too much or too bright lipstick
  • 70. 70 Keys to Successful Radio Interviews • Keep your answers short Generally only one or two sound bites will be used • If it’s a phone interview, stand up • Be expressive and animated • Speak clearly and at a moderate pace
  • 71. 71 Keys to Successful Print Interviews • While often longer, use only a small portion of what you say gets used • In the longer format, it’s easier to get off track • Remember your key message and deliver it • Flag your key messages by saying things like “the most important point” or “what people should really know is”
  • 72. 72 Keys to Successful Print Interviews • Don’t let your guard down. Remember anything you say can be included in the story • Hard questions don’t mean that the reporter has taken a side • If you are unsure of an answer, tell the reporter that you will get back to them
  • 73. 73 Summary • Prepare for your interview Know your key messages Practice Dress appropriately • Deliver your key messages • Think about your audience Use your voice Maintain eye contact • Stay on message
  • 74. 74 Conclusion • Use Faces & Voices recovery messaging to tell your recovery story • Make it personal • Use your message in all parts of your life with Family and friends Neighbors and co-workers Media and public officials Always!
  • 75. 75 Why Is It Important To Share Our Stories If I Only Knew How Important It Is To Put A Face On Recovery!!
  • 76. 76 Unite to Face Addiction 2015 Rally for Recovery Washington DCAnd once you have shared your story- you will join thousands of us who have United to Face Addiction
  • 77. 77 Kim Manlove, Director Indiana Addictions Issues Coalition Mental Health America of Indiana kim.m@the24group.org 317-331-5949
  • 78. Advocating for Change Presenters: • Gary Mendell, MBA, Founder and CEO, Shatterproof • Kim Manlove, MS, AB, Director, Indiana Addictions Issues Coalition Advocacy Track Moderator: Wendy Spencer, CEO, Corporation for National and Community Service

Editor's Notes

  1. There are several ways that you can use the materials on this DVD: 1). Watch the video and have a discussion about it. 1). Use the video as a training tool and stop and start as you go along, using the training materials. 2). Use this complete PowerPoint of the Our Stories Have Power Messaging Training. Portions of it appear in the video. We recommend that people giving this training watch the video carefully as well as attend a training if possible. You can add slides about your organization to the presentation. Getting started: 1). Have everyone in the room introduce themselves and give their name, organization and affiliation to the recovery movement. 2). Trainer introduce him or herself (using the messaging) 3). Review materials in packet (Make packets using the other materials on the DVD and make your own agenda) 4). Ask 2-3 people what they expect to get out of the training Technical notes: Before you start the training, put together folders with all of the training materials and distribute them to participants. The folders should include: Agenda Copy of the PowerPoint presentation Questions and Answers Tip Sheet Recovery Messaging Congressional Quarterly article Advocacy with Anonymity brochure Optional materials to include: Participant directory Information on your organization Information on other recovery resources in your community Have the following hand-outs available to pass out during the training: Person in recovery worksheet Family member worksheet Feedback form for mock interviews Have the following materials available for yourself: Trainer Teaching Tips (includes Feedback form) Interview topics for practice interviews. There are possible topics in the Recovery Messaging Questions and Answers document. You can write something down to hand out when you get to the mock interview section of the training or write something and post it for people to read.
  2. 1). Review the goals 2). Talk about your experiences with the training and how transformative it was, using real examples of how you’ve used the messaging in your life; how you used to talk about your recovery and how you talk about it today.
  3. Faces & Voices represents the organized recovery community and we’re going to be talking a lot about the recovery community today. Who are we talking about? And as you can see from some of these pictures, the recovery community – people in recovery, family members, friends and allies – is out in force all over the country – as active and visible members of the community.
  4. This training was developed by Faces & Voices of Recovery, our national recovery community organization.
  5. The national recovery movement has grown dramatically over the last 10 years. Where once it was not acceptable to talk about your recovery in public, today it is. And Faces & Voices is best know for organizing and mobilizing the recovery community – to get involved in their community and government and help change things
  6. When Faces & Voices of Recovery was founded in 2001, a core principle was and remains that there are many pathways to recovery, just like with other health issues. There are many ways to get well and Faces & Voices is working to make sure that every person can find the path that will work for them.
  7. Many of you may recognize this man. His name is Bill White and he’s an author and long time advocate of what he calls “the new recovery movement.” We’re going to be referencing some of Bill’s work throughout the day. White issues a challenge that I think is appropriate for all of us … To step forward to shape this history with our stories, our time and our talents. And that’s what we’re doing today.
  8. All around us there – we are awash in messages, asking us to buy things, vote for people, go to eat a certain way or make certain lifestyle choices Ask people to be open-minded as this new recovery messaging unfolds Technical note: This training is all about messaging, it’s important to help people understand what a message is at this point in the training.
  9. The research findings were exciting: 1). The recovery community wants to tell its story if it will help more people get well 2). The general public supports efforts to help people with alcohol and drug problems
  10. This messaging can be used in many different circumstances.
  11. Technical note: Ask people to take out their Advocacy with Anonymity brochure Discuss the traditions in the flyer; you can read directly from it. Many people aren’t familiar with them and it’s useful to review the material. Find out if there are any questions.
  12. There’s a reason that these messages were developed. Our society has failed to address alcohol and other drug problems and help people who have yet to find recovery. And here’s what some of those problems are. That’s why we’re speaking out.
  13. The messaging is about the solution. Technical note: You can use examples of advocacy campaigns and/or people telling their recovery story that have changed policy or attitudes. One example is the Wellstone-Domenici Mental Health and Addiction Equity Act – when members of Congress told their recovery stories as part of their advocacy for a new law.
  14. Technical note: Ask people to take out their Recovery Message memo. The trainer should have one on hand as well. Important to ask people to be open-minded again.
  15. The recovery community is people in recovery, family members, friends and allies. That’s why there’s messaging here for family members. Technical note: Refer to the Recovery Messaging memo, where it’s included.
  16. Technical note: Refer to the Recovery Messaging hand out for more explanation. Read one or two examples and the reason why it’s not in the message.
  17. Technical note: This next section is about words that are commonly used to talk about people and addiction. It’s a chance to have a discussion if you want to. Since you’re going to be asking participants to develop their own message that will work for them, they can discuss some words that they think work to help them best develop their own message.
  18. ABUSE – substance abuse, alcohol abuse, division of substance abuse – these words reinforce a negative message with the general public and policy makers Treatment works – A better way of saying this may be that there are effective treatments or treatment worked for me. Faces & Voices and other research has found that for far too many people, treatment hasn’t “worked.” And effective treatment is the first step to long-term recovery. Technical note: Pick one word or phrase and discuss that in depth and encourage people to pick up the book and think about it after the training and as they advocate
  19. Technical note: This is an opportunity to increase participants’ level of confidence about the messaging.
  20. Faces & Voices message goals: These are the goals for our national movement and why we have developed the messages. When you do this training in your community, you can spend a few minutes thinking first about what your messages goals are.
  21. We’re used to talking to whoever we’re in a room or on the phone with. This is different.
  22. From the earliest age, we’re taught to answer what we’re asked. For people in recovery, we’re often taught to be brutally honest. Staying on message is a technique that everyone can learn. One of the tools you can use are what are called bridging phrases. It’s a way to help you say what you want to say and stay on message. Here are some examples. Ask people if they have other ideas for bridging phrases or ones that they’ve heard before. Refer to page 5 in the Media Tips for Sample Bridging phrases.
  23. Here are some examples of staying on message. Technical note: Ask people to take out their Questions and Answers hand out. There are other examples in the hand out.
  24. We’ve used these resources in the training today. When you get home, please take a look at them and use them when you’re preparing for an interview or to give a talk. Now we’re going to do some interviews using our personal messages. Technical note: At this point in the training, you can do mock interviews. Ask people to pull out their personal messaging worksheet. Prepare interview topics ahead of time. There are possible topics in the Recovery Messaging Questions and Answers document. Pair people up for mock interviews, with one person being the reporter and the other person the interviewee. Distribute Feedback forms to each pair. Critique/Switch After everyone’s had a chance to do it; come back as a group and debrief
  25. Technical Note: Insert the name of the trainer and contact information here.